CARBACID INVESTMENTS PLC |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.85 KES | +0.30% |
|
-2.32% | +12.33% |
| Mar. 15 | Carbacid Investments plc Reports Earnings Results for the Half Year Ended January 31, 2024 | CI |
| 2023 | Carbacid Investments plc Reports Earnings Results for the Full Year Ended July 31, 2023 | CI |
Valuation
| Fiscal Period: July | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,803 | 2,233 | 2,013 | 3,058 | 2,944 | 4,307 |
| Enterprise Value (EV) 1 | 1,965 | 1,496 | 1,194 | 2,077 | 2,717 | 4,209 |
| P/E ratio | 9.39 x | 8.44 x | 6.2 x | 7.37 x | 4.16 x | 5.28 x |
| Yield | 6.36% | 7.99% | 8.86% | 5.83% | 14.7% | 10.1% |
| Capitalization / Revenue | 3.72 x | 3.54 x | 2.95 x | 3.37 x | 2.08 x | 2.5 x |
| EV / Revenue | 2.61 x | 2.37 x | 1.75 x | 2.29 x | 1.92 x | 2.45 x |
| EV / EBITDA | 4.64 x | 5.39 x | 4.09 x | 5.93 x | 4.21 x | 5.52 x |
| EV / FCF | 8.34 x | 6.83 x | 7.87 x | 13.3 x | 11.9 x | -33.1 x |
| FCF Yield | 12% | 14.6% | 12.7% | 7.53% | 8.43% | -3.02% |
| Price to Book | 0.92 x | 0.71 x | 0.62 x | 0.88 x | 0.78 x | 1.03 x |
| Nbr of stocks (in thousands) | 254,852 | 254,852 | 254,852 | 254,852 | 254,852 | 254,852 |
| Reference price 2 | 11.00 | 8.760 | 7.900 | 12.00 | 11.55 | 16.90 |
| Announcement Date | 11/16/18 | 9/29/19 | 11/23/20 | 11/1/21 | 10/31/22 | 10/24/23 |
1KES in Million2KES
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: July | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 753.2 | 630.5 | 682.9 | 906.6 | 1,415 | 1,721 |
| EBITDA 1 | 423.8 | 277.4 | 292 | 350.3 | 645.3 | 761.9 |
| EBIT 1 | 370.7 | 223.8 | 237.4 | 289.5 | 573.6 | 679 |
| Operating Margin | 49.22% | 35.5% | 34.76% | 31.94% | 40.54% | 39.45% |
| Earnings before Tax (EBT) 1 | 378.9 | 377.2 | 427 | 540.3 | 913.8 | 1,081 |
| Net income 1 | 298.5 | 264.6 | 324.7 | 415.1 | 707.7 | 816 |
| Net margin | 39.64% | 41.96% | 47.54% | 45.79% | 50.02% | 47.42% |
| EPS 2 | 1.171 | 1.038 | 1.274 | 1.629 | 2.777 | 3.202 |
| Free Cash Flow 1 | 235.6 | 219.1 | 151.6 | 156.3 | 229.1 | -127.1 |
| FCF margin | 31.28% | 34.74% | 22.2% | 17.25% | 16.19% | -7.38% |
| FCF Conversion (EBITDA) | 55.58% | 78.97% | 51.92% | 44.63% | 35.5% | - |
| FCF Conversion (Net income) | 78.92% | 82.8% | 46.7% | 37.67% | 32.37% | - |
| Dividend per Share 2 | 0.7000 | 0.7000 | 0.7000 | 0.7000 | 1.700 | 1.700 |
| Announcement Date | 11/16/18 | 9/29/19 | 11/23/20 | 11/1/21 | 10/31/22 | 10/24/23 |
1KES in Million2KES
Estimates
Balance Sheet Analysis
| Fiscal Period: July | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 839 | 737 | 820 | 981 | 227 | 97.8 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 236 | 219 | 152 | 156 | 229 | -127 |
| ROE (net income / shareholders' equity) | 10% | 8.57% | 10.2% | 12.3% | 19.4% | 20.5% |
| ROA (Net income/ Total Assets) | 6.94% | 4.07% | 4.16% | 4.8% | 8.55% | 8.86% |
| Assets 1 | 4,303 | 6,501 | 7,802 | 8,656 | 8,272 | 9,206 |
| Book Value Per Share 2 | 11.90 | 12.30 | 12.80 | 13.70 | 14.90 | 16.30 |
| Cash Flow per Share 2 | 0.1700 | 0.8600 | 0.0200 | 0.6600 | 0.0600 | 0.4600 |
| Capex 1 | 34.4 | 37.7 | 49.9 | 126 | 180 | 468 |
| Capex / Sales | 4.57% | 5.98% | 7.3% | 13.85% | 12.72% | 27.2% |
| Announcement Date | 11/16/18 | 9/29/19 | 11/23/20 | 11/1/21 | 10/31/22 | 10/24/23 |
1KES in Million2KES
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
16.85
Average target price
-
| 1st Jan change | Capi. | |
|---|---|---|
| +12.33% | 32.76M | |
| -2.77% | 58.4B | |
| +21.16% | 12.81B | |
| +68.03% | 9.7B | |
| -7.67% | 3.62B | |
| +16.66% | 3.29B | |
| +14.57% | 3.17B | |
| -14.53% | 2.12B | |
| -10.11% | 1.84B | |
| +5.71% | 1.72B |
- Stock Market
- Equities
- CARB Stock
- Financials Carbacid Investments plc